INJECTABLE ROCURONIUM BROMIDE DIN 02539489
Health Canada record
| Active ingredient(s) | ROCURONIUM BROMIDE 10 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | M03AC09 ROCURONIUM BROMIDE |
| Original market date | |
| Current status date | 29-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Omega Laboratories Ltd. (now Juno Pharma Canada Inc.) — licence 100277, not currently licensed, last inspection rating C (2025-05-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ROCURONIUM BROMIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02529831 | ROCURONIUM BROMIDE INJECTION | JAMP PHARMA CORPORATION | Solution | ROCURONIUM BROMIDE 10 MG | Marketed |
| 02469774 | ROCURONIUM BROMIDE INJECTION | JUNO PHARMA CANADA INC. | Solution | ROCURONIUM BROMIDE 10 MG | Marketed |
| 02498820 | ROCURONIUM BROMIDE INJECTION | AURO PHARMA INC | Solution | ROCURONIUM BROMIDE 10 MG | Marketed |
| 02517744 | ROCURONIUM BROMIDE INJECTION | HIKMA CANADA LIMITED | Solution | ROCURONIUM BROMIDE 10 MG | Marketed |
| 02528657 | ROCURONIUM BROMIDE INJECTION | EUGIA PHARMA INC. | Solution | ROCURONIUM BROMIDE 10 MG | Marketed |
| 02318415 | ROCURONIUM BROMIDE INJECTION | SANDOZ CANADA INCORPORATED | Solution | ROCURONIUM BROMIDE 10 MG | Marketed |
| 02442752 | ROCURONIUM BROMIDE INJECTION | STERIMAX INC | Solution | ROCURONIUM BROMIDE 10 MG | Approved |
| 02318121 | ROCURONIUM BROMIDE INJECTION | PFIZER CANADA ULC | Solution | ROCURONIUM BROMIDE 10 MG | Cancelled Post Market |
| 02382415 | ROCURONIUM BROMIDE INJECTION | OMEGA LABORATORIES LIMITED | Solution | ROCURONIUM BROMIDE 10 MG | Cancelled Post Market |
| 02390566 | ROCURONIUM BROMIDE INJECTION SDZ | SANDOZ CANADA INCORPORATED | Solution | ROCURONIUM BROMIDE 10 MG | Cancelled Pre Market |
| 02108208 | ZEMURON | MERCK CANADA INC | Solution | ROCURONIUM BROMIDE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 31180 | 2023-07-10 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement Between Two Manufacturers |
International API supply for ROCURONIUM BROMIDE
9 valid EDQM Certificates of Suitability from 9 holders. 14 active FDA Drug Master Files.
Request a quote for INJECTABLE ROCURONIUM BROMIDE